Expression and function of efflux drug transporters in the intestine

被引:268
作者
Takano, M [1 ]
Yumoto, R [1 ]
Murakami, T [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Program Pharmaceut Sci, Dept Pharmaceut & Therapeut,Minami Ku, Hiroshima 7348551, Japan
关键词
ABC transporter; P-glycoprotein; multidrug resistance-associated protein 2; breast cancer resistance protein; oral bioavailability; transporter-mediated drug interaction;
D O I
10.1016/j.pharmthera.2005.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of drug transporters expressed in the body control the fate of drugs by affecting absorption, distribution, and elimination processes. In the small intestine, transporters mediate the influx and efflux of endogenous or exogenous substances. In clinical pharmacotherapy, ATP-dependent efflux transporters (ATP-binding cassette [ABC] transporters) expressed on the apical membrane of the intestinal epithelial cells determine oral bioavailability, intestinal efflux clearance, and the site of drug-drug interaction of certain drugs. The expression and functional activity of efflux transporters exhibit marked interindividual variation and are relatively easily modulated by factors such as therapeutic drugs and daily foods and beverages. In this article, we will summarize the recent findings regarding the intestinal efflux transporters, especially P-glycoprotein (P-gp or human multidrug resistance gene [MDR] 1), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:137 / 161
页数:25
相关论文
共 244 条
[51]  
Feng Guang-Hua, 2003, Hepatobiliary Pancreat Dis Int, V2, P300
[52]   Rifampin and Rifabutin drug interactions - An update [J].
Finch, CK ;
Chrisman, CR ;
Baciewicz, AM ;
Self, TH .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) :985-992
[53]   EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-TUMORS AND TISSUES [J].
FOJO, AT ;
UEDA, K ;
SLAMON, DJ ;
POPLACK, DG ;
GOTTESMAN, MM ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) :265-269
[54]   Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: In vitro in vivo correlation [J].
Fricker, G ;
Drewe, J ;
Huwyler, J ;
Gutmann, H ;
Beglinger, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (07) :1841-1847
[55]  
FRIEND DG, 1976, ARCH SURG-CHICAGO, V111, P14
[56]   The effect of rifampin treatment on intestinal expression of human MRP transporters [J].
Fromm, MF ;
Kauffmann, HM ;
Fritz, P ;
Burk, O ;
Kroemer, HK ;
Warzok, RW ;
Eichelbaum, M ;
Siegmund, W ;
Schrenk, D .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05) :1575-1580
[57]   Importance of P-glycoprotein at blood-tissue barriers [J].
Fromm, MF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (08) :423-429
[58]   Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans [J].
Fuhr, U .
CLINICAL PHARMACOKINETICS, 2000, 38 (06) :493-504
[59]   Role of P-glycoprotein in pharmacokinetics and drug interactions of digoxin and β-methyldigoxin in rats [J].
Funakoshi, S ;
Murakami, T ;
Yumoto, R ;
Kiribayashi, Y ;
Takano, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (07) :1455-1463
[60]   Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin [J].
Geick, A ;
Eichelbaum, M ;
Burk, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14581-14587